Neudle.com: L dopa

Differential
(Click to cross reference)

abdominal protrusion

acetylcholine

acromegaly

adolescent medicine

advances in neurology

adverse drug reaction

affective disorders

agitation

akathisia

akinesia of eyelid function

alcohol, neurologic complications with

alcoholism

algorithm

alien hand syndrome

alpha methyldopa hydrazine

amphetamines, dyskinesia associated with

amygdala

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, etiology of

anasarca

anemia, iron deficiency

anesthesia, general

ankle edema

anticholinergic drugs

anticholinergic drugs, side effects of

aphasia, progressive, primary

apraxia of eyelid opening

apraxia, constructional

aprazolam

aqueduct of Sylvius, stenosis

arm swing, reduced

arrhythmia, cardiac

artane

arterial dissection, aorta, cerebral symptoms with

aspartate aminotransferase

aspiration

asterixis

ataxia

attention deficit disorder with hyperactivity

atypical

audiogram

auditory and vestibular pathways

autonomic cardiovascular reflexes

autonomic dysfunction

autonomic dysfunction, evaluation of

autonomic nervous system

axillary nerve

Babinski sign

ballismus, bilateral

basal ganglia, infarction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

benserazide

benzodiazepine

beta adrenergic blocker

brain implant, polymeric

brain transplantation

burst suppression pattern, electroencephalogram

CAT scan, emission, abnormal

catecholamine

catechol-o-methyltransferase inhibitor

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortical atrophy

cerebral infarction, subcortical

cerebral ischemia

cerebral palsy

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrovascular accident

cerebrovascular disease

chromosomal abnormality

Clinical Pathologic Conference(C.P.C.)

controversies in neurology

Coombs test, positive

coprolalia

cortical-basal ganglionic degeneration

cyst, arachnoid, infant

dantrolene sodium

deanol

degenerative diseases of CNS

dementia, subcortical

dementia, treatment of

deprenyl

depression

desipramine

developmental milestones, loss of

differential diagnosis

dilantin

diplopia

disability rating scale, neurological

disability, neurological

diurnal variation

dizziness

dopa responsive dystonia

dopamine receptor, D2

dopaminergic dysfunction

drug induced neurologic disorders

dyskinesia, buccal lingual facial

dyskinesia, drug induced

dystonia musculorum deformens

dystonia, children

dystonia, etiology of

dystonia, evaluation of

dystonia, face

dystonia, focal

dystonia, painful

dystonia, prevalence of

dystonia, symptomatic

dystonia, treatment of

echolalia

efficacy

electroconvulsive therapy

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, periodic complexes

electroencephalogram, triphasic delta waves

encephalopathy, progressive

epidemiology of neurology

equinovarus

ergotamine

evidence-based research

excitotoxin

exercise

extrapyramidal movement disorder, progressive

eye movement, disorders of

failed medical management

fine motor function, impaired

frontal behavioral spatial syndrome

gamma amino butyric acid

gastrointestinal bleeding

gastrostomy

gaze palsy

gaze palsy, supranuclear

genetic neurologic disorders

genetic screening

genetic testing

Gilles de la Tourette syndrome

glabellar sign

globus pallidus, stimulation

glomus jugulare tumor

groaning

guanidine

hallucination

hallucination, visual

head injury, brain stem lesion after

head injury, prognosis in

hepatic encephalopathy

hepatic encephalopathy, treatment of

hepatolenticular degeneration(Wilson's disease)

heralding manifestation

Huntington's chorea, presymptomatic detection of

hydrocephalus

hydroxyindole acetic acid 5(5HIAA)

hydroxytryptophan L-5(L-5 HTP)

hypotension, systemic

iatrogenic neurologic disorders

inclusion bodies, eosinophilic cytoplasmic

inclusion bodies, intranuclear

intranasal medication

L-dopa, controlled release

L-dopa, delayed treatment in Parkinsonism

L-dopa, drug interactions with and side effects of

L-dopa, enteral infusion, continuous

L-dopa, intravenous

L-dopa, liquid

L-dopa, plasma concentration

L-dopa, potentiators of

Lewy body disease, diffuse

liver function enzymes

lobar atrophy

locus ceruleus, lesion of

lorazepam

madopar

manganese intoxication

memory, defect of recent

memory, impairment of

meningitis

mental status, abnormal

methysergide

metoclopramide

microangiopathy, brain

migraine, treatment of

mimics

Mini Mental Status Examination

misdiagnosis

mitochondrial disease

molecular genetics

monoamine oxidase inhibitors

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, treatment of

multiple sclerosis, diet in

multiple sclerosis, treatment of

multiple system atrophy

muscle atrophy, static

myasthenic syndrome, treatment of

neoplasm, hormone producing

neoplasm, hormone producing, ectopic

neurochemistry

neuroendocrinology

neuroleptic

neuroleptic malignant syndrome

neuroleptic sensitivity

neuroleptic, atypical

neurologic complications of, surgery

neurologic disease, diagnoses of

neurologic disease, tempo

neuronal degeneration

neuronal intranuclear inclusion disease

neuroophthalmology

neuropathology

neuropathology, brain

neuropathy

neuropathy, peripheral

neuroprotective agents

nigrostriatal pathway

norepinephrine

nortriptyline

obsessive-compulsive disorder

occupational neurologic disorders

ocular myopathy

ocular myopathy, differential diagnosis

olanzapine

old age, neurology of

ondansetron

ophthalmoplegia

oral contraceptives

oral contraceptives, choreiform movements with

orthostatic hypotension

orthostatic hypotension, idiopathic

orthostatic hypotension, treatment of

parasympathetic nervous system

paresthesias

Parkinson disease

Parkinson disease, akinetic form

Parkinson disease, arteriosclerotic

Parkinson disease, asymmetric onset

Parkinson disease, axial symptoms

Parkinson disease, benign tremulous

Parkinson disease, complications, late

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, diet restricted in protein

Parkinson disease, differential diagnosis of

Parkinson disease, drug holiday

Parkinson disease, drug induced

Parkinson disease, duration

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, heterogeneity of

Parkinson disease, intractable

Parkinson disease, juvenile

Parkinson disease, late onset

Parkinson disease, L-dopa nonresponsive

Parkinson disease, misdiagnosis

Parkinson disease, mode of onset

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, postencephalitic

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, rapid onset

Parkinson disease, rapid progression

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, unilateral

Parkinson disease, wearing off

Parkinson disease, young onset

Parkinsonism multiple-system atrophy

Parkinsonism plus syndrome

Parkinsonism syndrome

paroxetine

parsidol

pathologic gambling

patient information and support

penguin silhouette sign

pergolide

periodic limb movements

periodic movements during sleep

persistent vegetative state

personality change

phenothiazine

phenothiazine, dyskinesia associated with

pregnancy, neurologic complications in

pretectal syndrome

prevention of neurologic disorders

PRKN gene

procyclidine

prognosis

progressive neurologic disorder

progressive supranuclear palsy

psychiatric problems in neurologic disorders

psychological testing

psychological testing, neurologic problems

psychomotor retardation

pure autonomic failure

putamen, lesion of

pyramidal tract dysfunction

pyridoxine

pyridoxine deficiency

pyruvate-kinase deficiency anemia

quetiapine

raphe nuclei

rapid onset dystonia parkinsonism

rasagiline

rash

Red flags

reserpine and reserpine like drugs

reserpine treatment in movement disorder

respirations in CNS disease

respiratory dyskinesias

restless arms syndrome

restless leg syndrome

retrocollis

retropulsion

reversible neurologic disorder

risk-benefit assessment

ritalin

Romberg's sign

ropinirole

ropinirole, prolonged release

saccadic eye movements, abnormal

safety

scoliosis

seizure

seizure, pyridoxine dependent

selective serotonin reuptake inhibitors

self-mutilation

sequencing difficulty

serotonin

serotonin antagonist

serum alanine aminotransferase

short stature

shunt procedure, ventricular-complications of

Shy-Drager syndrome

sinemet

singing

single photon emission computed tomography

skin, biopsy

sleep

sleep pathology and physiology

small vessel disease

smell

Smell Identification Test

solvent

speech disorder

speech disorder, childhood

speech, soft

spinocerebellar ataxia

spinocerebellar ataxia type 1

spinocerebellar ataxia type 2

spinocerebellar ataxia type 3/Machado Joseph disease

stem cell transplantation

stereotaxic surgery

stereotyped behavior

stereotyped behavior, drug induced

stereotypy

steroid therapy, CNS treatment and complications with

stimulation, deep brain

subthalamic nucleus deep brain stimulation

swallow evaluation

sweating

sweating, abnormality of

sympathetic nervous system

sympathomimetic drugs

syncope

synucleinopathy

syphilis, neurologic complications with

systemic illness

tandem gait, ataxic

tardive dyskinesia

tardive dyskinesia, treatment of

thalamus, focused ultrasound ablation

toxins, nervous system

trauma

trazodone

treatment of neurologic disorder

tremor, surgical treatment of

tremor, thalamic stimulation for suppression of

tremor, treatment of

tricyclic antidepressant

trigeminal neuralgia

trinucleotide repeats

tripping

twins

tyrosine hydroxylase deficiency

varicella zoster virus

varicella zoster virus, encephalitis

vertigo, treatment of

vision, blurred

visual impairment

visual symptoms

visuospatial disturbance

walking, difficulty with

white matter disease, subcortical

wide based gait

Showing articles 250 to 300 of 352 << Previous Next >>

Drugs that Reduce Efficacy of Levodopa
(Letter) , NEJM 295:153876., Hausner,R., 1976

Studies with Bromocriptine Part 2. Double-blind Comparison with Levodopa in Idiopathic Parkinsonism
Neurol 26:511, Kartzinel,R.,et al, 1976

Treatment of Parkinson's Disease with Bromocriptine
NEJM 295:1400, Lieberman,A.,et al, 1976

Narcolepsy:REM Sleep Suppression by L-Dopa, (Letter)
NEMJ 294:849, Gilbert,J.C.,et al, 1976

Levodopa-Induced Myoclonus
Arch Neurol 32:331-334, Klawans,H.L., 1975

Huntington's Chorea-Deficiency of Y-Aminobutynic Acid in Brain
NEJM 288:337, 1973, 289:104, 1973, 292:10295., Perry,T.,et al, 1975

Important Advances in Clinical Medicine
West J Med 123:128, Mosier,J.M.,et al, 1975

Progressive Supranuclear Palsy-Case Study
NEJM 293:346, Richardson,E.P., 1975

Catecholamines & Neurologic Diseases
NEJM 293:274, Moskowitz,M.A.,et al, 1975

Facial Hyperkinesis
BMJ 626, Jun1974., , 1974

Prolonged Levodopa Therapy
BMJ 383, Feb 1973., , 1973

Start Hesitation-A Side Effect of Long-Term Levodopa Therapy
NEJM 288:1113, Ambani,L.,et al, 1973

Modern Treatment of Parkinson's Disease
Excerpta Medica, 2:1972 Sept., , 1972

Methyldopahydrazine as an Adjunct to L-Dopa Therapy in Parkinsonism
Neurol 22:384, Chase,T.,et al, 1972

Use of L-Dopa in the Detection of Presymptomatic Huntington's Chorea
NEJM 286:1332, Klawans,H.,et al, 1972

Treatment of Parkinsonism
NEJM 287:1047, Young,R.R., 1972

Metabolic Responses to Acute & Chronic L-Dopa Administration in Patients with Parkinsonism
NEJM 287:729, Sirtori,C.,et al, 1972

Treatment for Parkinsonism
Other than Levodopa, BMJ 741, 1972 March., , 1972

Occurence of Positive Coombs Test in Patients Treated with Levodopa
NEJM 286:1401, Joseph,C., 1972

Drug Therapy of Parkinsonism
NEJM 287:20, Yahr,M.,et al, 1972

Presymptomatic Detection of Huntington's Chorea
BMJ 540, 1972 Sept., , 1972

Modern Treatment of Parkinson's Disease
Excerpta Medica 2:1972 Aug., , 1972

Implications of Amphetamine-Induced Stereotyped Behavior as a Model for Tardive Dyskinesias
Arch Gen Psychiat 27:502-507, Rubovits,R.,et al, 1972

Modern Treatment of Parkinson's Disease
Excerpta Medica, 2:1971 Jun-Jul., , 1971

Modern Treatment of Parkinson's Disease
Excerpta Medica 2:1971 Oct., , 1971

How does L-Dopa Work in Parkinsonism
Lancet 784, 1971 Apr., Sandler,M., 1971

Cholinergic & Dopaminergic Mechanisms in Huntington's Chorea
Life Sciences 10:405 1971., Aquilonius,S.,et al, 1971

Modern Treatment of Parkinson's Disease
Excerpta Medica l:Nov-Dec, , 1971

Combined Treatment of Parkinsonian Tremor with Propranolol & Levodopa
J Neurol Sci 14:491, , 1971

Drug-Induced Movement Disorders
Postgrad Med 180, 1971, Sept., North,R., 1971

Levodopa Therapy:Why Wait? Patient Care June 15
1971., , 1971

Manic Response to Levodopa Therapy
NEJM 285:788, Ryback,R.,et al, 1971

L-Dopa in the Treatment of Parkinson's Disease
Postgrad Med 47:153, Martin,W., 1970

Monoamine Oxidase Inhibitor & L-Dopa
BMJ 3:388, Hunter,H.R.,et al, 1970

Dopamine & Disease
C M A Journ 103:824, Barbeau,A., 1970

Neuropsychopharmcology & the Affective Disorders
NEJM 281:197, 1969 (three parts) ., Schildkraut,J.J., 1969

An 81-Year-Old Man with Imbalance and Memory Impairment
, Golbe,L.I.,et al,

Thalamus L-Sign: A Potential Biomarker of Neonatal Partial, Prolonged Hypoxic-Ischemic Brain Injury or Hypoglycemic Encephalopathy
AJNR 43:919-925, Misser, S.K.,et al, 2022

The Phenotypic Continuum of ATP1A3-Related Disorders
Neurol 99:e1511-e1526, Vezyroglou,A., et al, 2022

Headache and Altered Mental Status
Neurol 90:e1267-e1270, Spera, K.M.,et al, 2018

Clinicopathologic Conference, Cerebral Infarction from Internal Carotid Occlusion Related to Sickle Cell Arteriopathy
NEJM 374:1265-1275, Case 10-2016, 2016

Dystonia in Children and Adolescents: A Systematic Review and a New Diagnostic Algorithm
JNNP 86:774-781, Van Egmond, M.E.,et al, 2015

Alternative Medicine and Alzheimer Disease
The Neurologist 14:299-306, Kelley,B.J. &Knopman,D.S., 2008

Dystonia
NEJM 355:818-829, Tarsy,D. &Simon,D.K., 2006

Dopa-responsive Dystonic Camptocormia
Neurol 66:1779, Van Gerpen,J.A., 2006

Familial Dopa-Responsive Cervical Dystonia
Neurol 66:599-601, Schneider,S.A.,et al, 2006

Progressive Myoclonic Epilepsies: A Review of Genetic and Therapeutic Aspects
Lancet Neurol 4:239-248, Shahwan, A., et al, 2005

Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003

Clinicopath Conf, Neuronal Ceroid Lipofuscinosis, Late-Onset Infantile Subtype
NEJM 347:672-680, Case 27-2002, 2002

Total Brain N-Acetylaspartate, A New Measure of Disease Load in MS
Neurol 54:15-19, Gonen,O.,et al, 2000

Showing articles 250 to 300 of 352 << Previous Next >>